Masimo has named Tim Benner as its new President, marking a key leadership appointment for the medical technology company. Effective August 3, 2026, Benner will lead Masimo’s global business operations, commercial strategy, and innovation efforts. The announcement comes as Masimo continues operating as a Danaher company and focuses on expanding its healthcare technology portfolio.
The company said Benner’s extensive experience in the medical technology industry and his leadership within Masimo make him well positioned to support the company’s next phase of growth.
Tim Benner Steps Into the President Role
Masimo announced that Tim Benner has been appointed President, effective August 3, 2026. In his new role, he will oversee the company’s worldwide business operations while driving commercial execution, innovation, and customer engagement.
Benner joined Masimo in June 2025 as Chief Marketing and Strategy Officer. He later became Chief Commercial Officer, where he led the company’s global commercial organization and helped strengthen customer relationships. According to Masimo, he also played an important role in shaping the company’s business strategy during its transition as part of Danaher.
The promotion reflects Masimo’s confidence in Benner’s leadership and industry expertise as the company continues to expand its presence in patient monitoring and healthcare technology.
More Than Three Decades of Industry Experience
Benner brings more than 30 years of experience in the medical technology sector. Throughout his career, he has held leadership positions at Edwards Lifesciences, Abbott, Terumo, Stryker, Inari Medical, and Masimo.
According to the company, his experience includes building commercial organizations, leading strategic growth initiatives, and supporting the launch and adoption of innovative medical technologies. His background spans sales, marketing, business strategy, and commercial operations across global healthcare markets.
Danaher Leadership Welcomes the Appointment
Julie Sawyer Montgomery, CEO Designate of Danaher, welcomed Benner’s appointment and said his leadership has already made a meaningful impact at Masimo. She noted that his strategic thinking, customer-focused approach, and commitment to innovation will help the company continue delivering advanced healthcare technologies.
Benner also expressed his enthusiasm for the new role. He said he is honored to serve as President of Masimo and looks forward to working with employees, customers, and partners worldwide. He added that becoming part of Danaher creates new opportunities to combine Masimo’s innovation with the Danaher Business System to improve patient care and deliver greater value to healthcare providers.
Focus on Innovation and Customer Partnerships
As President, Benner will lead Masimo’s global operations with a focus on innovation, commercial growth, and stronger customer partnerships. His responsibilities include supporting the company’s patient monitoring technologies while helping expand its presence in healthcare markets around the world.
Masimo said it remains committed to developing technologies that help clinicians make informed decisions and improve patient outcomes. Under Benner’s leadership, the company plans to continue investing in innovation while strengthening its relationships with healthcare providers and customers.
About Masimo
Masimo is a global medical technology company and part of Danaher. The company develops patient monitoring, diagnostic, and automation technologies used in hospitals and healthcare facilities worldwide.
Masimo is widely known for its Masimo SET pulse oximetry technology. According to the company, the technology has been validated in more than 100 independent studies and is used to monitor more than 200 million patients each year. Masimo also states that its pulse oximetry technology serves as the primary system at the top 10 U.S. hospitals listed in the 2026 Newsweek World’s Best Hospitals rankings.
With Tim Benner now serving as President, Masimo aims to build on its history of medical innovation while expanding its global reach and supporting healthcare providers with advanced patient monitoring solutions.
